dr. kerrigan on design and findings of the profile 1001 trial in ros1-mutated nsclc
Published 4 years ago • 87 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:25
dr. kerrigan on remaining challenges in alk nsclc
-
1:51
dr. riess on ros1 fusions in lung cancer
-
1:15
dr. li discusses the profile crizotinib clinical trials
-
1:06
dr. goldman on targeted therapy options for egfr-, alk-, and ros1-mutated nsclc
-
4:55
ros1-rearranged nsclc
-
2:18
dr. wakelee on first trial to combine antiangiogenesis agents with immunotherapy in nsclc
-
1:53
ros-1 rearrangements: what are they?
-
2:37
upfront treatment of ros1-rearranged nsclc
-
1:53
dr. kris on the crizotinib clinical trials
-
2:11
dr. low on osimertinib versus dacomitinib in egfr-mutant nsclc
-
46:20
innovative clinical trial designs - 06/22/23
-
4:00
roecsg 2022 - anne rajkumar - integration of plan review into resident clinical didactics
-
4:17
using sequencing data to identify outbreaks in a hospital
-
2:28
rachel karchin – pioneering computational cancer genomics
-
49:50
breast cancer advances in research & treatment
-
1:34:11
lung cancer early diagnosis and the novel artificial intelligence
-
2:55
using ai to detect lung cancer before it develops
-
3:43
designing a covid-19 patient particle chamber
-
14:13
tumor deconvolution dream challenge: inferring immune... - andrew gentles - recomb/rsg 2018